| Resources |
|
| Government |
| Quick access to information based on government's structure
|
|
 |
|
|
Limited Coverage Drugs - Special Authority Criteria
| Generic Name / Strength / Form |
| clopidogrel |
| Criteria |
Approval Period |
| 1. In secondary prevention of coronary, cerebral and peripheral
vascular occlusion and embolization where a person has experienced treatment
failure or intolerance to ASA. |
1. Indefinite |
| OR |
| 2. Documented post-Percutaneous Coronary Intervention. |
2. Thirty days |
| OR |
| 3. Documented post-stent procedure with Drug Eluting Stent. |
3. Up to twelve months |
| OR |
| 4.
For hospital-diagnosed Acute Coronary Syndrome (unstable angina or non-ST
elevation myocardial infarction)
PLUS
in combination with ASA.
Patients are not eligible for coverage if they:
- have severe Congestive Heart Failure, or
- are on oral anticoagulants, or
- have had coronary revascularization (Coronary Artery Bypass Graft) in the past three months.
|
4. Thirty days |
Practitioner Exemptions
- No practitioner exemptions
Special Notes
- For any cancer related condition, please contact the British Columbia Cancer Agency at (604) 877-6098 ext. 4610.
Online Forms (PDF)
Click on the link to complete a special authority request form.
|
|
|